TM01 @ #ACR23: Daunting Case of Diarrhea 65 yo F w/ sero+RA + 2ndary SjS p/w 4 wks diarrhea -CT a/p: thickening of cecum, ascending colon -Colonoscopy path: ischemia -R colectomy: enterocoelic lymphocytic phlebitis, no underlying vasculitis. Dx: IgG4-RD, serum IgG4⬆️ @RheumNow https://t.co/jQ57U5EjPo

TM02 @ #ACR23: 19yo F w/ SLE p/w 1w DOE PMHx: SLE (malar, LN, AIHA, ITP) on HCQ x 10yrs Dx? HCQ-induced CM (curvilinear bodies, vacuolar degen) ⭐️RF for HCQ-induced cardio-toxicity: - older age, F - HCQ > 10 yrs, ⬆️ daily dose - hx of cardiac dz - renal insuffic @RheumNow https://t.co/GgzB2Chgra

TM03 @ #ACR23 40 yo healthy F p/w swelling, red papule, hyperpigmentation, firmness, & tightness on R semi-body Dx? Unilateral generalized morphea (UGM) No guidelines for tx of morphea or UGM This case report showed success w/ IVMP + PO Pred & MTX & TCZ for maint @RheumNow https://t.co/iOVqhwmCVz

Come and visit poster 1410 in the poster hall today. I will be sharing our work using the ASAS @Official_ASAS referral guidelines for earlier diagnosis of Axial Spondyloarthritis, Chan A et al Abst#1410 #ACR23 @RheumNow https://t.co/jB3FHPSBqs

CAR-T cell Rx show promise for drug-free remission in refractory #SLE without affecting vaccination response despite depleting CD19+ plasmablasts https://t.co/WXa4ADfcF6 abst#0606 @RheumNow #ACR23 https://t.co/ga4DCcbMhD

Argentinian #SLE Registry data eval Ro Ab & outcomes of 1500+ SLE pts. 40% had +Ro Ab. Pts w/+Ro Ab had⬇️complements, other+autoAb, Sjogren's, Raynaud's, interstitial pneumonitis, pericarditis & tended to be on steroids or MTX @RheumNow #ACR23 abst#0561

Promising! #Cenerimod is a selective S1P1 Receptor modulator has potential in SLE through modulating lymphocyte trafficking, inflammation, and autoantigen transport. Phase 2 showed reduced T/B lymphocytes, autoAb levels, and secretions of IFN-a. #abstr0584 @rheumNow #ACR23

RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.

Great work by @Yuz6Yusof ANA positive and diagnosis , prediction tool to rule out/ in autoimmune pathology. 1-High interferon score. 2-FH autoimmune disease. 3- More criteria. ?Monogenic error of immune system , ?genome assessment . @RheumNow , Daily recap

I vote for the ❤️ Several abstracts evaluated cardiovascular event prevalence and screening tools using ECHO, carotid ultrasound as current CV risk calculators are inadequate when assessing SLE CV risk. See my blog - just published @RheumNow https://t.co/XLc0YHtJ0B https://t.co/oF0fXBRM6O

1-Can we prevent RA ? Vagotomy? 2-CV events in auto immune rheumatic disease pregnancies. 3-CVS vasculitis , challenges and role of Brain biopsy And others…….. https://t.co/BX8bDSX1M3 @RheumNow , daily recap #ACR23

Sunday recap @RheumNow Very interesting abstracts: https://t.co/BX8bDSX1M3 1- Fecal calprotectin in SpA population. 2-SLE; high or low steroids? Rapid or slow taper? 3-Molecular biomarkers for PAH in SLE. 4-Repeating imaging in ? Chronic back pain? And others …….

#ACR23 Abstr#0784 Beyond renal response, let’s also focus on kidney function and Steroid-sparing effect. Post-hoc analysis of Phase 2 RCT showed Obinutuzumab preserved eGFR by 4ml/min/1.73m2/year with greater number of pts achieving <7.5mg/d of prednisolone bs PBO @RheumNowNews https://t.co/2hW74UF1ta

#ACR23 Abstr#0590 Graphical Abstract makes it easy to follow 👏. Data using EHR showed that in #SLE with Diabetes, SGLT2-i vs DPP4-i was associated with reduced risks of developing AKI, CKD, ESRD, hospitalisation, and heart failure. Genital infection is common @RheumNowNews https://t.co/Iku6LqoYVb

Cognitive function in PMR @DrTrishHarkins 71% cognitively impaired! Markedly higher than population level #ACR23 @RheumNow https://t.co/0KTnssktKz https://t.co/XyjFzioiqB